NEW YORK (GenomeWeb News) – Affymetrix said after the close of the market on Thursday that its second quarter revenues climbed 7 percent year over year.

The Santa Clara, Calif.-based microarray firm said that for the three months ended June 30, total revenues increased to $85.4 million from $79.5 million a year ago, beating the average Wall Street estimate of $83.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

In Genome Biology this week: miRNAs linked to diffuse large B-cell lymphoma outcomes, database of bird genomes, and more.